Cargando…

Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils

Stroke is the third cause of death and the first of permanent adult disability. Pretreatment with policosanol and atorvastatin has been effective in experimental models of cerebral ischaemia in rodents. The objective was to compare the therapeutic effects of policosanol and atorvastatin in a model o...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, V., Ravelo, Y., Noa, M., Mas, R., Pérez, Y., Oyarzábal, A., Mendoza, N., Valle, M., Jiménez, S., Sánchez, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928726/
https://www.ncbi.nlm.nih.gov/pubmed/24591737
_version_ 1782304303759753216
author Molina, V.
Ravelo, Y.
Noa, M.
Mas, R.
Pérez, Y.
Oyarzábal, A.
Mendoza, N.
Valle, M.
Jiménez, S.
Sánchez, J.
author_facet Molina, V.
Ravelo, Y.
Noa, M.
Mas, R.
Pérez, Y.
Oyarzábal, A.
Mendoza, N.
Valle, M.
Jiménez, S.
Sánchez, J.
author_sort Molina, V.
collection PubMed
description Stroke is the third cause of death and the first of permanent adult disability. Pretreatment with policosanol and atorvastatin has been effective in experimental models of cerebral ischaemia in rodents. The objective was to compare the therapeutic effects of policosanol and atorvastatin in a model of global cerebral ischaemia in gerbils. Gerbils were distributed into seven groups, a negative control and six with ischaemia-reperfusion-induced global cerebral ischemia (one vehicle positive control, two policosanol (100 and 200 mg/kg), two atorvastatin (10 and 20 mg/kg) and one aspirin (60 mg/kg) group). Treatments were given 4 h after ischaemia induction. Effects on ischemia-reperfusion-induced symptoms, hyperlocomotion, damage of pyramidal hipoccampal neurons and increased plasma oxidative markers were investigated. Positive, not negative controls, exhibited clinical symptoms, hyperlocomotion, neuronal damage and increased plasma oxidative markers. Policosanol (100 and 200 mg/kg) reduced significantly ischemia-reperfusion-induced symptoms, the frequency of symptomatic animals, histological scores of neuronal damage and plasma oxidative markers as compared with the positive control group. Atorvastatin (10 and 20 mg/kg) decreased significantly the symptoms and histological scores, but unchanged the frequency of symptomatic gerbils and oxidative variables. Only the highest dose of policosanol (200 mg/kg) and atorvastatin (20 mg/kg) reduced significantly ischemia reperfusion-induced hyperlocomotion, policosanol being the most effective. Aspirin 60 mg/kg lowered significantly symptom score, the rate of symptomatic gerbils and hyperlocomotion versus the positive controls, but failed to modify oxidative parameters. In conclusion, postreperfusion treatment with policosanol and atorvastatin was effective for ameliorating symptoms, hyperlocomotion and neurological damage of hippocampal CA1 neurons in gerbils with ischemia-reperfusion-induced global cerebral ischemia, but only policosanol reduced increased plasma oxidative variables.
format Online
Article
Text
id pubmed-3928726
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39287262014-03-03 Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils Molina, V. Ravelo, Y. Noa, M. Mas, R. Pérez, Y. Oyarzábal, A. Mendoza, N. Valle, M. Jiménez, S. Sánchez, J. Indian J Pharm Sci Research Paper Stroke is the third cause of death and the first of permanent adult disability. Pretreatment with policosanol and atorvastatin has been effective in experimental models of cerebral ischaemia in rodents. The objective was to compare the therapeutic effects of policosanol and atorvastatin in a model of global cerebral ischaemia in gerbils. Gerbils were distributed into seven groups, a negative control and six with ischaemia-reperfusion-induced global cerebral ischemia (one vehicle positive control, two policosanol (100 and 200 mg/kg), two atorvastatin (10 and 20 mg/kg) and one aspirin (60 mg/kg) group). Treatments were given 4 h after ischaemia induction. Effects on ischemia-reperfusion-induced symptoms, hyperlocomotion, damage of pyramidal hipoccampal neurons and increased plasma oxidative markers were investigated. Positive, not negative controls, exhibited clinical symptoms, hyperlocomotion, neuronal damage and increased plasma oxidative markers. Policosanol (100 and 200 mg/kg) reduced significantly ischemia-reperfusion-induced symptoms, the frequency of symptomatic animals, histological scores of neuronal damage and plasma oxidative markers as compared with the positive control group. Atorvastatin (10 and 20 mg/kg) decreased significantly the symptoms and histological scores, but unchanged the frequency of symptomatic gerbils and oxidative variables. Only the highest dose of policosanol (200 mg/kg) and atorvastatin (20 mg/kg) reduced significantly ischemia reperfusion-induced hyperlocomotion, policosanol being the most effective. Aspirin 60 mg/kg lowered significantly symptom score, the rate of symptomatic gerbils and hyperlocomotion versus the positive controls, but failed to modify oxidative parameters. In conclusion, postreperfusion treatment with policosanol and atorvastatin was effective for ameliorating symptoms, hyperlocomotion and neurological damage of hippocampal CA1 neurons in gerbils with ischemia-reperfusion-induced global cerebral ischemia, but only policosanol reduced increased plasma oxidative variables. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3928726/ /pubmed/24591737 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Molina, V.
Ravelo, Y.
Noa, M.
Mas, R.
Pérez, Y.
Oyarzábal, A.
Mendoza, N.
Valle, M.
Jiménez, S.
Sánchez, J.
Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title_full Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title_fullStr Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title_full_unstemmed Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title_short Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils
title_sort therapeutic effects of policosanol and atorvastatin against global brain ischaemia-reperfusion injury in gerbils
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928726/
https://www.ncbi.nlm.nih.gov/pubmed/24591737
work_keys_str_mv AT molinav therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT raveloy therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT noam therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT masr therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT perezy therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT oyarzabala therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT mendozan therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT vallem therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT jimenezs therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils
AT sanchezj therapeuticeffectsofpolicosanolandatorvastatinagainstglobalbrainischaemiareperfusioninjuryingerbils